Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Joshua

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|July 27, 1985
Indication for therapy in multiple myeloma: should it be stage or stability?D E Joshua, A Wearne, H Kronenberg
Australian and New Zealand Journal of Medicine|October 1, 1985
Monitoring myeloma: light chain isotype suppression. A new parameterA Wearne, D E Joshua, H Kronenberg
Blood Reviews|March 1, 1994
Mechanisms of the escape phase of myelomaD E Joshua, J Gibson, R D Brown
The Medical Journal of Australia|July 7, 1984
Haemophilia and ITPJ Gibson, D E Joshua, K A Rickard
International Journal of Cancer|May 15, 1979
Immune suppression in BALB/c mice bearing the plasmacytoma TEPC-183: evidence for normal lymphocyte but defective macrophage functionD E Joshua, G Brown, I C MacLennan
British Journal of Haematology|December 1, 1994
Multiple myeloma: why does the disease escape from plateau phase?D E Joshua, R D Brown, J Gibson
Acta Haematologica|January 1, 1985
Idiopathic myelofibrosis complicated by lymphoma. Report of two casesR J Epstein, D E Joshua, H Kronenberg
Praxis|June 21, 2012
[Multiple myeloma]D C Hsu, P Wilkenfeld, D E Joshua
Leukemia & Lymphoma|November 1, 1994
Prognostic factors in myeloma: what they tell us about the pathophysiology of the diseaseD E Joshua, R D Brown, J Gibson
Leukemia & Lymphoma|November 1, 1995
Primary amyloidosis co-presenting with cervical and massive intra-abdominal lymphadenopathyE Segalov, J Gibson, D E Joshua, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|July 27, 1985
Indication for therapy in multiple myeloma: should it be stage or stability?D E Joshua, A Wearne, H Kronenberg
Australian and New Zealand Journal of Medicine|October 1, 1985
Monitoring myeloma: light chain isotype suppression. A new parameterA Wearne, D E Joshua, H Kronenberg
Blood Reviews|March 1, 1994
Mechanisms of the escape phase of myelomaD E Joshua, J Gibson, R D Brown
The Medical Journal of Australia|July 7, 1984
Haemophilia and ITPJ Gibson, D E Joshua, K A Rickard
International Journal of Cancer|May 15, 1979
Immune suppression in BALB/c mice bearing the plasmacytoma TEPC-183: evidence for normal lymphocyte but defective macrophage functionD E Joshua, G Brown, I C MacLennan
British Journal of Haematology|December 1, 1994
Multiple myeloma: why does the disease escape from plateau phase?D E Joshua, R D Brown, J Gibson
Acta Haematologica|January 1, 1985
Idiopathic myelofibrosis complicated by lymphoma. Report of two casesR J Epstein, D E Joshua, H Kronenberg
Praxis|June 21, 2012
[Multiple myeloma]D C Hsu, P Wilkenfeld, D E Joshua
Leukemia & Lymphoma|November 1, 1994
Prognostic factors in myeloma: what they tell us about the pathophysiology of the diseaseD E Joshua, R D Brown, J Gibson
Leukemia & Lymphoma|November 1, 1995
Primary amyloidosis co-presenting with cervical and massive intra-abdominal lymphadenopathyE Segalov, J Gibson, D E Joshua, et al.
Pageof 9